Tamoxifen is the present clinical most commonly estrogen acceptor resistance, has become the estrogen acceptor positive breast cancer the golden standard of endocrine treatment.

• 三苯氧胺是目前临床最常用的雌激素受体拮抗剂，已成为激素受体阳性乳腺癌内分泌治疗的金标准。